IN a previous study, we demonstrated the presence of a neutrophil recruitment inhibitory factor (NRIF) in the supernatants of LPS-stimulated macrophages. Recently, the purification of a 54kDa protein, identified as the macrophagederived neutrophil chemotactic factor (MNCF) was reported. Since NRIF and MNCF are obtained under the same conditions, and, since the intravenous administration of TNF-and IL-8 inhibits neutrophil migration, we have investigated whether MNCF could be responsible for this inhibitory activity. After affinity chromatography of the macrophage supernatants on a n-galactose column, the inhibitory activity was recovered in both the unbound (D-gal-) and bound (D-gal+) fractions, with MNCF being found in the n-gal fraction. Further gel f'dtration of the latter on Superdex 75 yielded a single peak containing both activities. In a cytotoxicity assay, most of the TNF found in the crude supernatants was recovered in the n-gal-fraction. Furthermore, the incubation of the D-gal-fraction with anti-TNFplus anti-IL-8 antisera partially prevents its inhibitory effect on neutrophil migration, but had no effect on the n-gal activity. Overall, these results suggest that the n-gal-inhibitory effect is partially mediated by TNF-and IL-8, and that MNCF accounts for the inhibition of neutrophil migration in vtvo by the D-gal fraction.
Introduction
Several studies have established that Gramnegative bacteraemia or circulating endotoxin decreases the ability of neutrophils to migrate into the inflammatory sites, a phenomenon which may play an important role in the evolution of sepsis.
It has been demonstrated that the impairment of neutrophil migration is mediated by inhibitory factors including tumour necrosis factor-cz (TNF-cz) 4 and interleukin 8 (IL-8). 5 Previous work from our laboratory demonstrated that the intravenous administration of LPS-stimulated macrophage supernatants also inhibits neutrophil migration to the inflammatory site following, exposure to various stimuli. When the supernatants were submitted to gel filtration on Sephacryl S-300, the in vivo neutrophil chemotactic inhibitory activity was detected mainly in a fraction which eluted in a volume corresponding to high molecular weight proteins (240-550 kDa). This fraction also inhibited the cell-dependent oedema induced by carrageenin 116 Mediators of Inflammation Vol 5 1996 or by ovalbumin in previously immunized rats. The cell-independent oedema induced by dextran was not affected by the S-300 active fraction. 7 This fraction was also able to inhibit the increase in neutrophil and eosinophil numbers in the bronchoalveolar lavage fluid of sensitized guinea-pigs as well as the ovalbumin-induced bronchoconstriction in these animals. 8 Recently, the purification of a 54kDa acidic protein, identified as the macrophage-derived neutrophil chemotactic factor (MNCF) was reported. 9 The When the D-gal-fraction was co-incubated with anti-TNF-a plus anti-IL-8 antisera, its inhibitory activity was partially prevented. In contrast, the same treatment did not alter the inhibitory effect of the D-gal + fraction on neutrophil migration ( Fig. I(B) ).
Eect of Superdex 75 fractions on the inhibition of neutrophil migration: The D-gal + preparation was chromatographed on a Superdex 75 column and the ability of some of the fractions to inhibit neutrophil migration in vivo was tested. Figure 2 shows that the inhibitory activity present in the crude supernatant was detected in the fraction eluted in a volume of 10 ml, corresponding to an apparent molecular weight of 54kDa, as shown by the chromatographic profile. In previous work this fraction was also demonstrated to contain neutrophil chemotactic activity. Electrophoretic analysis of the D-gal-fraction showed 
